Status:
COMPLETED
Enhanced Assistance During Radiotherapy for Unmet Essential Needs
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
American Society of Clinical Oncology
Conditions:
Bone Cancer
Brain Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a prospective single-arm study of an enhanced assistance intervention for patients with unmet essential needs undergoing \>10 fractions of radiotherapy comparing delay-free completion of radio...
Eligibility Criteria
Inclusion
- At least 18 years of age.
- Planned to receive or currently receiving a protracted course of curative-intent (neoadjuvant, definitive, or postoperative) radiotherapy.
- For the purposes of this study, radiotherapy must consist of \>10 fractions (if radiotherapy not yet initiated) or \>15 additional fractions after the date of consent (if radiotherapy initiated prior to study consent).
- Be willing to undergo radiotherapy at the Barnes-Jewish Hospital location.
- Indicate at least 1 unmet essential need, including food insecurity, transportation insecurity, housing instability, utility needs, childcare needs, or other financial insecurity.
- Accept a referral to and meet with a social worker.
- Have unmet essential needs that will not be able to be fully addressed by standard assistance. This determination can be made by the assigned social worker or by the patient after they meet with the social worker.
- Ability to understand and willingness to sign an IRB approved written informed consent document. Legally authorized representatives may sign and give informed consent on behalf of study participants.
Exclusion
- Planned or scheduled to undergo radiotherapy simulation more than 28 days from the date of consent.
- Admitted to the hospital and not expected to undergo \>10 fractions of radiotherapy as an outpatient.
- Undergoing treatment for anaplastic thyroid cancer. Patients with anaplastic thyroid cancer have a relatively low likelihood of completing radiotherapy due to the aggressive disease course.
Key Trial Info
Start Date :
October 4 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 8 2025
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT06582849
Start Date
October 4 2024
End Date
August 8 2025
Last Update
August 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110